Table 4 Molecular docking parameter table.

From: Deciphering the mechanisms of Yinlan Tiaozhi capsule in treating hyperlipidemia by combining network pharmacology, molecular docking and experimental verification

Target protein

Docking parameters

Naringenin

Ferulic acid

ALB

Binding energy/kJ mol−1

− 8.3

− 6.1

(4l9k)

Participating amino acid residues (H-Bonds/π-Interactions)

H-donor LEU-185, TYR-138

H-donor ARG-117, TYR-138

TNF

Binding energy/kJ mol−1

− 5.8

− 5.0

(2az5)

Participating amino acid residues (H-Bonds/π-Interactions)

H-donor TYR 151/pi-pi TYR 59

H-donor LEU 120/pi-pi TYR 59

IL6

Binding energy/kJ mol−1

− 5.8

− 5.1

(1il6)

Participating amino acid residues (H-Bonds/π-Interactions)

H-donor ARG 105

H-donor GLU 107, SER 108

PPARG

Binding energy/kJ mol−1

− 6.6

− 5.7

(2fvj)

Participating amino acid residues (H-Bonds/π-Interactions)

H-donor LYS 457, GLN 470

H-donor LEU 465, GLN 470, TYR 473

VEGFA

Binding energy/kJ mol−1

− 7.8

− 6.8

(5n21)

Participating amino acid residues (H-Bonds/π-Interactions)

H-donor ASP 323, SER 349

H-donor ASP 323, SER 349, ILE 418